CN105732660A - 左氧氟沙星中间体的制备方法 - Google Patents
左氧氟沙星中间体的制备方法 Download PDFInfo
- Publication number
- CN105732660A CN105732660A CN201410751395.9A CN201410751395A CN105732660A CN 105732660 A CN105732660 A CN 105732660A CN 201410751395 A CN201410751395 A CN 201410751395A CN 105732660 A CN105732660 A CN 105732660A
- Authority
- CN
- China
- Prior art keywords
- dihydro
- methyl
- pyrido
- fluoro
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 title claims abstract description 12
- 229960003376 levofloxacin Drugs 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- 239000003960 organic solvent Substances 0.000 claims abstract description 16
- 239000003513 alkali Substances 0.000 claims abstract description 10
- 239000012046 mixed solvent Substances 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 125000004494 ethyl ester group Chemical group 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 2
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 10
- 239000002904 solvent Substances 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 238000001914 filtration Methods 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 230000003292 diminished effect Effects 0.000 description 8
- 239000012065 filter cake Substances 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- NMGLVHXJOMBIJW-UHFFFAOYSA-N 1h-benzimidazole;dihydrochloride Chemical compound Cl.Cl.C1=CC=C2NC=NC2=C1 NMGLVHXJOMBIJW-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- VXGYRCVTBHVXMZ-UHFFFAOYSA-N quinoline-6-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CC=C21 VXGYRCVTBHVXMZ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- XNIVKSPSCYJKBL-UHFFFAOYSA-N 2h-1,2-benzoxazine-6-carboxylic acid Chemical compound O1NC=CC2=CC(C(=O)O)=CC=C21 XNIVKSPSCYJKBL-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- DTQVDTLACAAQTR-DYCDLGHISA-N trifluoroacetic acid-d1 Chemical compound [2H]OC(=O)C(F)(F)F DTQVDTLACAAQTR-DYCDLGHISA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410751395.9A CN105732660B (zh) | 2014-12-10 | 2014-12-10 | 左氧氟沙星中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410751395.9A CN105732660B (zh) | 2014-12-10 | 2014-12-10 | 左氧氟沙星中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105732660A true CN105732660A (zh) | 2016-07-06 |
CN105732660B CN105732660B (zh) | 2017-11-21 |
Family
ID=56239773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410751395.9A Active CN105732660B (zh) | 2014-12-10 | 2014-12-10 | 左氧氟沙星中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105732660B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108404990A (zh) * | 2018-05-08 | 2018-08-17 | 邳州易萨新型材料有限公司 | 一种用于合成左氟沙星药物中间体的催化剂及其应用 |
CN111620889A (zh) * | 2019-12-27 | 2020-09-04 | 上虞京新药业有限公司 | 一种左氧氟沙星中间体的制备方法 |
CN114478572A (zh) * | 2022-01-26 | 2022-05-13 | 上虞京新药业有限公司 | 一种左氧氟羧酸的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002048138A1 (en) * | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial quinolones |
JP2003180390A (ja) * | 2001-10-11 | 2003-07-02 | Daiichi Fine Chemical Co Ltd | 光学活性フェノキシプロパン誘導体の製法 |
CN1496409A (zh) * | 2001-03-07 | 2004-05-12 | ��һ��������ҩ��ʽ���� | 光学活性的丙氧基苯胺衍生物的制备方法 |
CN101648960A (zh) * | 2009-09-04 | 2010-02-17 | 浙江嘉善诚达药化有限公司 | 氧氟沙星的制备方法 |
CN102850376A (zh) * | 2012-06-18 | 2013-01-02 | 浙江大学 | 一种左旋氧氟沙星及氧氟沙星的一步合成方法 |
CN103755722A (zh) * | 2013-12-06 | 2014-04-30 | 浙江大学 | 一种左旋氧氟沙星及氧氟沙星的合成方法 |
-
2014
- 2014-12-10 CN CN201410751395.9A patent/CN105732660B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002048138A1 (en) * | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial quinolones |
CN1496409A (zh) * | 2001-03-07 | 2004-05-12 | ��һ��������ҩ��ʽ���� | 光学活性的丙氧基苯胺衍生物的制备方法 |
JP2003180390A (ja) * | 2001-10-11 | 2003-07-02 | Daiichi Fine Chemical Co Ltd | 光学活性フェノキシプロパン誘導体の製法 |
CN101648960A (zh) * | 2009-09-04 | 2010-02-17 | 浙江嘉善诚达药化有限公司 | 氧氟沙星的制备方法 |
CN102850376A (zh) * | 2012-06-18 | 2013-01-02 | 浙江大学 | 一种左旋氧氟沙星及氧氟沙星的一步合成方法 |
CN103755722A (zh) * | 2013-12-06 | 2014-04-30 | 浙江大学 | 一种左旋氧氟沙星及氧氟沙星的合成方法 |
Non-Patent Citations (2)
Title |
---|
顾海宁 等: ""左旋氧氟沙星合成的新工艺研究"", 《高校化学工程学报》 * |
鲍继胜 等: ""左氟沙星的微波催化合成"", 《合成化学》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108404990A (zh) * | 2018-05-08 | 2018-08-17 | 邳州易萨新型材料有限公司 | 一种用于合成左氟沙星药物中间体的催化剂及其应用 |
CN111620889A (zh) * | 2019-12-27 | 2020-09-04 | 上虞京新药业有限公司 | 一种左氧氟沙星中间体的制备方法 |
CN114478572A (zh) * | 2022-01-26 | 2022-05-13 | 上虞京新药业有限公司 | 一种左氧氟羧酸的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105732660B (zh) | 2017-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103724261B (zh) | 一种硫酸羟基氯喹啉的工业化制备方法 | |
JP6201595B2 (ja) | 2−ヒドロキシメチル−2,3−ジヒドロ−チエノ[3,4−b][1,4]ジオキシンの製造方法 | |
JP7038263B2 (ja) | モルホリノキナゾリン化合物の製造方法及びその中間体 | |
CN105732660A (zh) | 左氧氟沙星中间体的制备方法 | |
CN112544621B (zh) | 一种制备2-(4-氯苯氧基)-丙氧胺的方法 | |
CN102617489B (zh) | 磺胺氯吡嗪钠的一种制备方法 | |
CN111892548B (zh) | 制备2,4,6-三(2-羟基4-正己氧基芳基)-1,3,5-三嗪及其中间体的方法 | |
CN101914064A (zh) | 一种磺胺氯哒嗪钠的制备方法 | |
CN107188888A (zh) | 一种制备甲磺酸迈瑞替尼的方法 | |
CN106831768A (zh) | 一种2,6‑二氯吡啶[3,4‑b]吡嗪的合成方法 | |
CN101139348A (zh) | 2-氨基-6-氯嘌呤的合成方法 | |
CN108623602A (zh) | 一种制备和纯化依鲁替尼的方法 | |
CN105348285B (zh) | 一种低成本高收率制备腺嘌呤的方法 | |
CN104418810A (zh) | 一种左西孟旦的合成新路线 | |
CN111018782B (zh) | 9-氨基吖啶及其衍生物的制备方法 | |
CN103193666A (zh) | 2-氨基-3-氯苯甲酸甲酯的制备方法 | |
JP6260385B2 (ja) | 2−ヒドロキシメチル−2,3−ジヒドロ−チエノ[3,4−b][1,4]ジオキシン−5,7−ジカルボン酸ジアルキルエステルの製造方法 | |
CN106632347B (zh) | 一种吡咯并吡嗪化合物及其盐的制备方法 | |
CN103992241A (zh) | N-取代苯基甘氨酸的制备方法 | |
CN110590683A (zh) | 一种靶向药物azd3759中间体的制备方法 | |
CN104402737A (zh) | 一种制备盐酸溴己新的新方法 | |
CN105622520A (zh) | 一种治疗非小细胞肺癌药物色瑞替尼(Ceritinib)的新中间体及其制备方法 | |
CN103755706A (zh) | 一种合成叶酸的环保制备方法 | |
CN102391170A (zh) | 一种n,n-二烯丙基-5-甲氧基色胺盐酸盐的制备方法 | |
CN102675189A (zh) | 二氢吡啶类钙通道拮抗剂关键中间体的制备方法以及丁酸氯维地平的合成 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 312500 No. 800, Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province Patentee after: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region after: China Patentee after: SHANGHAI JINGXIN BIOLOGICAL MEDICAL Co.,Ltd. Patentee after: Shaoxing Jingxin Pharmaceutical Co.,Ltd. Address before: 312500 No. 800, Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province Patentee before: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: SHANGHAI JINGXIN BIOLOGICAL MEDICAL Co.,Ltd. Patentee before: SHANGYU JINGXIN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |